A St. Louis jury yesterday announced a $70 million talcum powder ovarian cancer verdict, in the third talcum powder ovarian cancer case to go to trial.
Medical research and jurors have found talcum powder ovarian cancer link.
Deborah Giannecchini, 62, used Johnson & Johnson’s (J&J) baby powder for feminine hygiene for more than four decades until her diagnosis with ovarian cancer three years ago.
Giannecchini has an 80 percent chance of dying in the next two years, and has undergone surgery, radiation and chemotherapy.
J&J and Imerys Hammered
A J&J unit was ordered to pay $65 million in punitive damages and 90 percent of about $2.5 million for medical costs and pain and suffering.
Co-defendant Imerys Talc America, the supplier of the talc, was hit with $2.5 million in punitive damages.
Juror: “J&J Didn’t Care”
As reported in Bloomberg News, the company should have provided a warning label on the product to let consumers decide whether to use talc, one juror Billie Ray, 76, of St. Louis, said after the trial. “It seemed like Johnson & Johnson didn’t pay attention,” she said. “It seemed like they didn’t care.”